New hope for kids with aggressive cancer that resists standard therapy
NCT ID NCT03165292
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 30 times
Summary
This study tested two stronger treatment plans for children with a rare and aggressive nerve cancer called very high-risk neuroblastoma. It included 34 children whose cancer did not shrink enough after standard chemotherapy. The goal was to see if these intensified treatments could help them live longer without the cancer coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VERY HIGH RISK NEUROBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fondazione IRCCS Istituto nazionaleTumori
Milan, 20133, Italy
-
Gustave Roussy
Villejuif, Val De Marne, 94805, France
-
Hospital Universitario Cruces
Cruces, 48903, Spain
-
Hospital Universitario y policnico La Fe
Valencia, 46026, Spain
-
Medizinische Universität Innsbruck
Innsbruck, 356020, Austria
-
Meyer children's Hospita
Florence, 50139, Italy
-
Ospedale Pediatrico Bambino Gesù
Roma, Italy
-
Princess Maxima Center
Utrecht, Netherlands
-
St. Anna Kinderspital GmbH
Vienna, 1090, Austria
Conditions
Explore the condition pages connected to this study.